These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9617066)

  • 21. A safe, effective, herbal antischistosomal therapy derived from myrrh.
    Sheir Z; Nasr AA; Massoud A; Salama O; Badra GA; El-Shennawy H; Hassan N; Hammad SM
    Am J Trop Med Hyg; 2001 Dec; 65(6):700-4. PubMed ID: 11791960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary clinical trials with oxamniquine, a new antischistosomal agent.
    Katz N; Pellegrino J; Grinbaum E; Chaves A; Zicker F
    Rev Inst Med Trop Sao Paulo; 1973; 15(1):25-9. PubMed ID: 4574207
    [No Abstract]   [Full Text] [Related]  

  • 23. Field trials with Oltipraz against Schistosoma mansoni in the Gezira Irrigated Area, Sudan.
    Kardaman MW; Fenwick A; el Igail AB; el Tayeb M; Bennett JL; Daffalla AA
    J Trop Med Hyg; 1985 Apr; 88(2):95-100. PubMed ID: 3897560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy of schistosomiasis.
    el Kouni MH
    R I Med; 1992 Apr; 75(4):212-6. PubMed ID: 1600256
    [No Abstract]   [Full Text] [Related]  

  • 25. The impact of chemotherapy on morbidity due to schistosomiasis.
    Richter J
    Acta Trop; 2003 May; 86(2-3):161-83. PubMed ID: 12745135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of schistosomicides against experimentally established Schistosoma mansoni infections in mice and hamsters.
    Yarinsky A
    J Toxicol Environ Health; 1975 Nov; 1(2):229-42. PubMed ID: 1206769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation and application of potential schistosome-associated morbidity markers within large-scale mass chemotherapy programmes.
    Webster JP; Koukounari A; Lamberton PH; Stothard JR; Fenwick A
    Parasitology; 2009 Nov; 136(13):1789-99. PubMed ID: 19523252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further clinical trials with oxamniquine (UK 4271), a new anti-schistosomal agent.
    da Silva LC; Sette H; Chamone DA; Sáez-Alquezar A; Punskas JA; Raia S
    Rev Inst Med Trop Sao Paulo; 1975; 17(5):307-11. PubMed ID: 1198006
    [No Abstract]   [Full Text] [Related]  

  • 29. The chemotherapy of schistosomiasis control.
    Bull Pan Am Health Organ; 1986; 20(1):68-9. PubMed ID: 3768593
    [No Abstract]   [Full Text] [Related]  

  • 30. Schistosomiasis can be prevented.
    Jordan P
    World Health Forum; 1988; 9(1):104-6. PubMed ID: 3254188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Better drugs for schistosomiasis.
    Drug Ther Bull; 1982 Dec; 20(25):98-9. PubMed ID: 7151713
    [No Abstract]   [Full Text] [Related]  

  • 32. [New drugs in the treatment of schistosomiasis].
    Bozdĕch V; Kocna A; Chválová M
    Cas Lek Cesk; 1984 Mar; 123(13):389-90. PubMed ID: 6713466
    [No Abstract]   [Full Text] [Related]  

  • 33. Schistosomiasis: challenges for control, treatment and drug resistance.
    Fenwick A; Webster JP
    Curr Opin Infect Dis; 2006 Dec; 19(6):577-82. PubMed ID: 17075334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic aspects of morbidity and acquired immunity in schistosomiasis control.
    Chan MS; Anderson RM; Medley GF; Bundy DA
    Acta Trop; 1996 Oct; 62(2):105-17. PubMed ID: 8988311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of 35972 RP (oltipraz) a new antischistosomal drug against Schistosoma haematobium, Schistosoma mansoni, and Schistosoma intercalatum.
    Gentilini M; Duflo B; Richard-Lenoble D; Brücker G; Danis M; Niel G; Meunier Y
    Acta Trop; 1980 Sep; 37(3):271-4. PubMed ID: 6106367
    [No Abstract]   [Full Text] [Related]  

  • 36. Antischistosomal activity of S-2-[[2-(2-thiazolylcarbamoyl) ethyl] amino] ethyl hydrogen thiosulfate in vitro and in vivo.
    Voigtman RE; Thompson PE
    J Parasitol; 1977 Dec; 63(6):1053-9. PubMed ID: 412938
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis of new praziquantel analogues: potential candidates for the treatment of schistosomiasis.
    Sadhu PS; Kumar SN; Chandrasekharam M; Pica-Mattoccia L; Cioli D; Rao VJ
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1103-6. PubMed ID: 22217873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Compliance analysis of the residents with mass medical treatment in areas highly endemic for schistosomiasis].
    Guo JG; Hu GH; Xiong YL
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(1):58-9. PubMed ID: 12567481
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence of HBs-Ag in schistosomiasis. (A) general aspects.
    el-Raziky EH; Zakaria S; el-Kalouby AH; Shaker ZA; Ata AA; el-Battawy Y
    Egypt J Bilharz; 1979; 6(1-2):1-10. PubMed ID: 263092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of metrifonate for selective population chemotherapy against urinary schistosomiasis in an endemic area at Mwanza, Tanzania.
    Rugemalila JB; Eyakuze VM
    East Afr Med J; 1981 Jan; 58(1):37-43. PubMed ID: 7215272
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.